← Back to Search

Electrical Stimulation

Personalized Electrical Brain Stimulation for Epilepsy

N/A
Recruiting
Led By Maryam M Shanechi, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients >= 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5-10 days
Awards & highlights

Study Summary

This trial is studying a way to improve electrical brain stimulation therapy for neuropsychiatric disorders by making it personalized.

Who is the study for?
This trial is for adults over 18 with epilepsy or brain tumors, who have electrodes already implanted in their brains for clinical monitoring. Participants should be healthy aside from their neurological condition, able to follow instructions, and not part of a vulnerable population like pregnant women or prisoners.Check my eligibility
What is being tested?
The study tests personalized electrical brain stimulation using models based on each patient's neural activity. It aims to improve treatment efficacy by adapting the therapy to individual responses and symptoms tracked via existing iEEG electrodes.See study design
What are the potential side effects?
While specific side effects are not listed, electrical brain stimulation may cause discomfort at the electrode site, headache, nausea, or changes in mood or cognition depending on the area of the brain being stimulated.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5-10 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5-10 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decoded depression symptom ratings based on neural activity
Secondary outcome measures
Hamilton Depression Rating (HAMD-6) self-reports
Visual Analog Scale (VAS) self-reports

Trial Design

1Treatment groups
Experimental Treatment
Group I: model-based electrical brain stimulationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
906 Previous Clinical Trials
1,596,263 Total Patients Enrolled
3 Trials studying Epilepsy
314 Patients Enrolled for Epilepsy
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,674 Total Patients Enrolled
9 Trials studying Epilepsy
5,316 Patients Enrolled for Epilepsy
University of California, San FranciscoOTHER
2,506 Previous Clinical Trials
15,238,530 Total Patients Enrolled
16 Trials studying Epilepsy
6,116 Patients Enrolled for Epilepsy

Media Library

Model-based Electrical Brain Stimulation (Electrical Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05327387 — N/A
Epilepsy Research Study Groups: model-based electrical brain stimulation
Epilepsy Clinical Trial 2023: Model-based Electrical Brain Stimulation Highlights & Side Effects. Trial Name: NCT05327387 — N/A
Model-based Electrical Brain Stimulation (Electrical Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05327387 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings in this clinical trial for prospective participants?

"Per the clinicaltrials.gov listing, this clinical trial is actively looking for volunteers; it was initially listed on February 8th 2022 and its information was last changed on April 6th 2022."

Answered by AI

What is the estimated enrollment for this clinical trial?

"Indeed, clinicaltrials.gov confirms that this medical experiment is presently recruiting participants. This trial was first advertised on February 8th 2022 and has since been modified as recently as April 6th 2022. The research team needs to recruit 25 patients from two locations."

Answered by AI
Recent research and studies
~12 spots leftby Mar 2026